These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9634524)

  • 41. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome.
    Entius MM; Keller JJ; Drillenburg P; Kuypers KC; Giardiello FM; Offerhaus GJ
    Clin Cancer Res; 2000 May; 6(5):1784-9. PubMed ID: 10815898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Muir-Torre syndrome.
    Bhaijee F; Brown AS
    Arch Pathol Lab Med; 2014 Dec; 138(12):1685-9. PubMed ID: 25427047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between family history and mismatch repair in colorectal cancer.
    Coggins RP; Cawkwell L; Bell SM; Crockford GP; Quirke P; Finan PJ; Bishop DT
    Gut; 2005 May; 54(5):636-42. PubMed ID: 15831908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Undectable expression of hMLH1 protein in sporadic colorectal cancer with replication error phenotype.
    Koike J; Yamada K; Takano S; Kikuchi Y; Hemmi H; Koi M; Tsujita K; Yanagita K; Yoshio T; Shimatake H
    Dis Colon Rectum; 1997 Oct; 40(10 Suppl):S23-8. PubMed ID: 9378008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. hMLH1, hMSH2 and hMSH6 mutations in hereditary non-polyposis colorectal cancer families from southern Sweden.
    Planck M; Koul A; Fernebro E; Borg A; Kristoffersson U; Olsson H; Wenngren E; Mangell P; Nilbert M
    Int J Cancer; 1999 Oct; 83(2):197-202. PubMed ID: 10471527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.
    Bapat BV; Madlensky L; Temple LK; Hiruki T; Redston M; Baron DL; Xia L; Marcus VA; Soravia C; Mitri A; Shen W; Gryfe R; Berk T; Chodirker BN; Cohen Z; Gallinger S
    Hum Genet; 1999 Feb; 104(2):167-76. PubMed ID: 10190329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microsatellite instability in Muir-Torre syndrome.
    Honchel R; Halling KC; Schaid DJ; Pittelkow M; Thibodeau SN
    Cancer Res; 1994 Mar; 54(5):1159-63. PubMed ID: 8118799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA mismatch repair and the significance of a sebaceous skin tumor for visceral cancer prevention.
    Kruse R; Ruzicka T
    Trends Mol Med; 2004 Mar; 10(3):136-41. PubMed ID: 15102357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer.
    Pucciarelli S; Agostini M; Viel A; Bertorelle R; Russo V; Toppan P; Lise M
    Dis Colon Rectum; 2003 Mar; 46(3):305-12. PubMed ID: 12626904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer.
    Müller A; Edmonston TB; Corao DA; Rose DG; Palazzo JP; Becker H; Fry RD; Rueschoff J; Fishel R
    Cancer Res; 2002 Feb; 62(4):1014-9. PubMed ID: 11861375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous cancer.
    Cesinaro AM; Ubiali A; Sighinolfi P; Trentini GP; Gentili F; Facchetti F
    Am J Dermatopathol; 2007 Aug; 29(4):351-8. PubMed ID: 17667167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic linkage analysis in hereditary non-polyposis colon cancer syndrome.
    Froggatt NJ; Koch J; Davies R; Evans DG; Clamp A; Quarrell OW; Weissenbach J; Hodgson SV; Ponder BA; Barton DE
    J Med Genet; 1995 May; 32(5):352-7. PubMed ID: 7616541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds.
    Scott RJ; McPhillips M; Meldrum CJ; Fitzgerald PE; Adams K; Spigelman AD; du Sart D; Tucker K; Kirk J
    Am J Hum Genet; 2001 Jan; 68(1):118-127. PubMed ID: 11112663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microsatellite instability in colorectal-cancer patients with suspected genetic predisposition.
    Calistri D; Presciuttini S; Buonsanti G; Radice P; Gazzoli I; Pensotti V; Sala P; Eboli M; Andreola S; Russo A; Pierotti M; Bertario L; Ranzani GN
    Int J Cancer; 2000 Jan; 89(1):87-91. PubMed ID: 10719736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Germline mutation analysis in hMLH 1 and hMSH 2 genes in hereditary nonpolyposis colorectal cancer and colorectal cancer patients with familial history].
    Wang Y; Friedl W; Propping P
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Dec; 15(6):333-6. PubMed ID: 9845760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications.
    Chung DC; Rustgi AK
    Ann Intern Med; 2003 Apr; 138(7):560-70. PubMed ID: 12667026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MSH-2 and MLH-1 protein expression in Muir Torre syndrome-related and sporadic sebaceous neoplasms.
    Morales-Burgos A; Sánchez JL; Figueroa LD; De Jesús-Monge WE; Cruz-Correa MR; González-Keelan C; Nazario CM
    P R Health Sci J; 2008 Dec; 27(4):322-7. PubMed ID: 19069357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. "Second hit" in sebaceous tumors from Muir-Torre patients with germline mutations in MSH2: allele loss is not the preferred mode of inactivation.
    Kruse R; Rütten A; Hosseiny-Malayeri HR; Bisceglia M; Friedl W; Propping P; Ruzicka T; Mangold E
    J Invest Dermatol; 2001 Mar; 116(3):463-5. PubMed ID: 11231323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.